FDA Adverse Event Injury Summary report: N

RHINAER STYLUS

MDR report key: 20132158 · Received September 4, 2024

Report

Report Number
3011625895-2024-00007
Event Type
Injury
Date Received
September 4, 2024
Date of Event
July 15, 2024
Report Date
September 3, 2024
Manufacturer
AERIN MEDICAL INC.
Product Code
GEI
UDI-DI
08886479300238
PMA / PMN Number
K221907
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NONE.

Description of Event or Problem · 0

PATIENT HAD HISTORY OF MULTIPLE NASAL AND SINUS PROCEDURES INCLUDING TOTAL SINUS SURGERY BY ANOTHER SURGEON, MEGA-ANTROSTOMIES, AND SCAR PRESENT IN OPERATIVE REGION. PATIENT PRESENTED WITH COUGH AND POSTNASAL DRAINAGE. SCAR WAS SEEN IN OPERATIVE AREA AND CHANGES PRESENT FROM PRIOR SURGERY. RHINAER WAS PERFORMED UNDER MILD SEDATION WITH LOCAL AND TOPICAL ANESTHESIA. THERE WERE A FEW AREAS TREATED ALONG THE COURSE OF THE POSTERIOR NASAL NERVE. NO TREATMENTS WERE OVERLAPPED. THERE WAS NOTHING UNUSUAL ABOUT THE PROCEDURE. POST PROCEDURE PATIENT WAS GIVEN ANTIBIOTIC, CEPHALEXIN, TOPICAL MUPIROCIN, AND INSTRUCTED TO USE SALINE RINSE. TWO WEEK FOLLOW UP, TREATMENT SITE WAS UNREMARKABLE AND COUGH HAD IMPROVED. DAYS FOLLOWING TWO WEEK FOLLOW UP, THE PATIENT BEGAN EPISTAXIS WHILE AT HOME. WENT BY EMS TO EMERGENCY DEPARTMENT. BY THE TIME OF ARRIVAL, BLEEDING CEASED. BLEEDING WAS TREATED WITH RHINO ROCKET EPISTAXIS DEVICE. MINIMAL TIME SPENT AT ED. TWO DAYS LATER, BLEEDING RECURRED BILATERALLY AND THE PATIENT WAS SEEN IN PHYSICIAN OFFICE. BLEEDING WAS POSTERIOR. PATIENT WAS TRANSFERRED TO HOSPITAL WHERE AN EMBOLIZATION WAS DONE TO THE INTERNAL MAXILLARY AND SPHENOPALATINE ARTERIES BILATERALLY. PATIENT WAS ALSO TRANSFUSED. THERE HAS BEEN NO FURTHER BLEEDING AND PATIENT HAS DONE WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1056283 RHINAER STYLUS RADIOFREQUENCY PROBE GEI AERIN MEDICAL INC. FG1393 08886479300238

Patients

Seq Age Sex Outcome Treatment
1 75 YR Female Hospitalization| O| R